Assessing treatment switch among patients with multiple sclerosis: A machine learning approach

Background: Patients with multiple sclerosis (MS) frequently switch their Disease-Modifying Agents (DMA) for effectiveness and safety concerns. This study aimed to develop and compare the random forest (RF) machine learning (ML) model with the logistic regression (LR) model for predicting DMA switch...

Full description

Bibliographic Details
Main Authors: Jieni Li, Yinan Huang, George J. Hutton, Rajender R. Aparasu
Format: Article
Language:English
Published: Elsevier 2023-09-01
Series:Exploratory Research in Clinical and Social Pharmacy
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2667276623000884